Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PPP1R35 is a regulatory subunit that interacts with protein phosphatase 1 (PP1), acting as a centrosomal protein required for proper centriole elongation and centriole-to-centrosome conversion. Its loss impairs centriole elongation and reduces centrosome number, highlighting a critical role in cell division and developmental processes. PPP1R35 functions via complex formation with RTTN (Rotatin), another centriolar protein, modulating the recruitment of structural and elongation machinery for centrioles. It harbors a conserved PP1-binding motif, but its centrosomal functions can be independent of direct PP1 interaction. PPP1R35 is enriched in vertebrate cells, and is suggested to play roles in ciliogenesis and centrosome homeostasis.
Not applicable; no drugs target this molecule directly. PPP1R35 functions as a scaffolding/regulatory subunit
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 1 regulatory subunit 35 (PPP1R35).